dc.contributor.author | Monje, Alberto | |
dc.contributor.author | Galindo-Fernández, Pablo | |
dc.contributor.author | Nart, José | |
dc.date.accessioned | 2024-05-23T09:38:10Z | |
dc.date.available | 2024-05-23T09:38:10Z | |
dc.date.issued | 2024 | |
dc.identifier.citation | Monje, Alberto; Galindo-Fernández, Pablo; Nart, José [et al.]. Supportive therapy following peri-implantitis treatment: a retrospective study on compliance. Clinical Oral Implants Research, 2024, p. 1-8. Disponible en: <https://onlinelibrary.wiley.com/doi/10.1111/clr.14257>. Fecha de acceso: 23 may. 2024. DOI: 10.1111/clr.14257 | ca |
dc.identifier.issn | 0905-7161 | ca |
dc.identifier.uri | http://hdl.handle.net/20.500.12328/4247 | |
dc.description.abstract | Background: The compliance rate with supportive therapy following peri-implantitis treatment (SPIT) remains unknown. The present retrospective study was carried out to assess the compliance rate and the factors influencing compliance in a private practice setting. Materials and Methods: Patients were divided into three groups according to compliance rate: regular compliance (RC ≥2 SPIT/year), erratic compliance (EC <2 SPIT/year), and non-compliance (NC <1 SPIT/year). Overall, 17 patient- (n = 8) and site-related variables (n = 9) were explored as potential confounders of compliance. The Chi2 test was applied to assess the association between categorical variables and determine the odds ratio (OR). Results: The study comprised 159 patients restored with 1075 implants, of which 469 were treated for peri-implantitis and met the inclusion criteria. A total of 57.2% were RC, 25.8% EC, and 17% NC. The multivariate analysis showed that smoking and grade C periodontitis reduced the likelihood of RC (OR = 0.28, p < .001) when compared to complete edentulism or non-smoking. Moreover, age demonstrated being associated with follow-up when SPIT was interrupted in EC and NC (OR = 0.94, p = .007). Conclusion: Comprehensive information, provided prior to peri-implantitis treatment, regarding the importance of adhering to SPIT after peri-implantitis treatment to achieve/maintain peri-implant health, resulted in ~60% regular compliance rate (NCT05772078). | ca |
dc.format.extent | 9 | ca |
dc.language.iso | eng | ca |
dc.publisher | Wiley | ca |
dc.relation.ispartof | Clinical Oral Implants Research | ca |
dc.rights | © 2024 The Authors. Clinical Oral Implants Research published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproductionin any medium, provided the original work is properly cited and is not used for commercial purposes. | ca |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | |
dc.subject.other | Implants dentals | ca |
dc.subject.other | Periimplantitis | ca |
dc.subject.other | Malaltia periodontal | ca |
dc.subject.other | Implantes dentales | ca |
dc.subject.other | Periimplantitis | ca |
dc.subject.other | Enfermedad periodontal | ca |
dc.subject.other | Dental implants | ca |
dc.subject.other | Peri-implantitis | ca |
dc.subject.other | Periodontal disease | ca |
dc.title | Supportive therapy following peri-implantitis treatment: a retrospective study on compliance | ca |
dc.type | info:eu-repo/semantics/article | ca |
dc.description.version | info:eu-repo/semantics/publishedVersion | ca |
dc.rights.accessLevel | info:eu-repo/semantics/openAccess | |
dc.embargo.terms | cap | ca |
dc.subject.udc | 616.3 | ca |
dc.identifier.doi | https://dx.doi.org/10.1111/clr.14257 | ca |